Status:
COMPLETED
Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Renal Cancer
Kidney Cancer
Eligibility:
All Genders
21-99 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the blood flow in kidney masses by using ultrasound microbubble contrast material, and to see if results from ultrasound contrast studies can predict if a kidn...
Eligibility Criteria
Inclusion
- Any adult patient who is planned or scheduled for surgical excision or biopsy of a solid or complex cystic renal mass would be eligible for the study
- Histology of the renal mass must be unknown at the time of enrollment
- Patients who have renal masses that are evident on conventional US imaging
- Patients will have a correlative abdominal CT and/or MRI
Exclusion
- Patients with any history of cardiac shunts.
- Patients with history of pulmonary hypertension or unstable cardiopulmonary conditions, including patients on mechanical ventilation.
- Patients without peripheral IV access
- Pregnant patients and children
- Patients with any known contrast allergies, allergy to perflutren, or any components of Definity or microbubble contrast
- Patients who have renal masses that are not evident on conventional US imaging
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00671411
Start Date
March 1 2008
End Date
November 1 2011
Last Update
December 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065